Drug Database
Back to search

United States· US:63629-8724_1dc2d61f-6958-4e0c-b4b4-ae659eb86e83

Oxaprozin

A oxaprozin product containing oxaprozin, registered in United States by Bryant Ranch Prepack. The same ATC class is registered in 4 of our 19 countries.

In shortageATC M01AE12Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedOxaprozinATCM01AE12REGISTER NO.US:63629-8724_1dc2d61…PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about oxaprozinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Oxaprozin is registered in 4 of 19 countries.

Countries holding a registration under ATC M01AE12 (oxaprozin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 3 of them publish a price we can compare per daily dose
Search oxaprozin products by name

Oxaprozin · ATC M01AE12

4 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Japan
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Oxaprozin
Manufacturer
Bryant Ranch Prepack
Country
United States (US)
ATC code
M01AE12
ATC class
Oxaprozin
Defined daily dose
0.9 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 1

  • ndc11
    6362987241
    100 TABLET in 1 BOTTLE (63629-8724-1)

Regulatory notes

UNII (FDA substance ID)
MHJ80W9LRB
OXAPROZIN
RxCUI 32613
Orange Book
A075845
AB
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Oxaprozin Tablet

Interactions

245 interactions on record for oxaprozin.

Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check oxaprozin against other medicinesHow interaction checks work

Oxaprozin · interactions on record

245 records

  • 57 severe
  • 140 moderate
  • 5 minor
  • 43 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxaprozin in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxaprozin products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Greece · Nisaid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/da52fbf7-7911-4cb3-bf9b-8ccd7882ed37
GET /v1/drugs/da52fbf7-7911-4cb3-bf9b-8ccd7882ed37?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "MHJ80W9LRB",
    "rxcui": "32613",
    "inchikey": "OFPXSFXSNFPTHF-UHFFFAOYSA-N",
    "display_name": "OXAPROZIN",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 3
  },
  "spl_meta": {
    "e881dca6-004e-1c3e-e053-2a95a90a02ab": {
      "match": "brand_token",
      "title": "OXAPROZIN TABLET, FILM COATED [ST MARY'S MEDICAL PARK PHARMACY]",
      "spl_version": "4",
      "published_date": "2026-05-25"
    }
  },
  "productid": "63629-8724_1dc2d61f-6958-4e0c-b4b4-ae659eb86e83",
  "productndc": "63629-8724",
  "dosage_form": "TABLET",
  "orange_book": {
    "appl_no": "075845",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "600MG",
        "product_no": "001",
        "approval_date": "Jan 31, 2001"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "OXAPROZIN",
  "shortage_reason": "Oxaprozin Tablet",
  "shortage_status": "current",
  "proprietary_name": "Oxaprozin",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA075845",
  "marketing_category": "ANDA",
  "nonproprietary_name": "Oxaprozin",
  "start_marketing_date": "20010131",
  "active_numerator_strength": "600"
}
API referenceMCP serverPlans

See everything about oxaprozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console